A member of Egypt’s Supreme Committee for Viruses at the Ministry of Higher Education and Scientific Research said on Sunday that the antiviral Sovaldi drug, used to treat Hepatitis C, has shown promising results in the treatment of COVID-19. In early 2020, Egypt’s EvaPharma partnered with America drug giant Gilead to supply the country with Sovaldi at a 99 percent discount, both for coronavirus treatment and Hep C treatment, as the country has the highest number of Hep C infections in the world. Patients with cirrhosis (liver failure) can safely take the drug, which sets it apart from other antivirals. While Sovaldi is on the market now for Hep C treatment, the drug has yet to be approved for coronavirus treatment. Egypt’s Health Ministry confirmed 993 new coronavirus cases and 55 deaths on Sunday.
Source: Egypt Independent January 11, 2021 09:45 UTC